Tracking mesonephric-like adenocarcinoma cases
Part of Cancer clinical trials.
This study is creating a registry to collect information from patients with a rare type of gynecologic cancer called mesonephric-like adenocarcinoma (MLA) and related types. By joining, you help doctors learn more about this cancer to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), or a related type (mesonephric carcinosarcoma or mesonephric-like carcinosarcoma).
- You speak and read English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
This study collects information from Chinese patients with a rare and aggressive type of cervical cancer called large cell neuroendocrine carcinoma. By tracking how the disease behaves and how patients respond, it aims to improve care for future patients.
This study is a registry that collects information about people with rectal cancer to help doctors learn more about the disease and its treatment. It focuses on patients receiving a certain treatment plan (TNT) or with a specific genetic marker (dMMR/MSI-H), and aims to improve future care.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study keeps a careful record of children, teens, and young adults with cancer (and some related growths) and may follow them over time. It helps researchers better track outcomes and future contact so care can improve.
This study follows people whose early esophageal adenocarcinoma was found during an endoscopy (ER) sample. The goal is to better understand what follow-up tests are needed based on higher-risk features and to watch for spread or incomplete removal.
Hear when a new Mesonephric-like Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.